Y-mAbs Therapeutics, Inc.
YMABDelisted Sep 16, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001722964
Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Y-mAbs Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 97 | 2 | −95 |
| Shares | 27.9M | 16.4K | −27.9M (−99.9%) |
| Value | $125.9M | $78.3K | −$125.8M (−99.9%) |
New holders (0)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (95)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.